{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:00:29Z","timestamp":1781078429692,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.msard.2025.106860","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:13:35Z","timestamp":1763374415000},"page":"106860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epstein-Barr virus seropositivity in a cohort of Sri Lankan patients with early multiple sclerosis: Preliminary case control study from South Asia"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2861-9822","authenticated-orcid":false,"given":"Shanindra","family":"De Alwis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohitha","family":"Muthugala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimsara","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6578","key":"10.1016\/j.msard.2025.106860_bib0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.msard.2025.106860_bib0002","series-title":"Vaccine Development For Epstein-Barr virus","first-page":"477","author":"Cohen","year":"2018"},{"issue":"20","key":"10.1016\/j.msard.2025.106860_bib0003","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.msard.2025.106860_bib0004","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1474-4422(09)70275-3","article-title":"Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score","volume":"8","author":"De Jager","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106860_bib0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.0b013e3181aa29fe","article-title":"Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI","volume":"73","author":"Farrell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106860_bib0006","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511545313.026","article-title":"Reactivation and lytic replication of EBV","author":"Kenney","year":"2007","journal-title":"Hum. Herpesvirus.: Biol. Ther. Immunoprophyl."},{"key":"10.1016\/j.msard.2025.106860_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101017","article-title":"Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impact","author":"Korsukewitz","year":"2024","journal-title":"Lancet Region. Health\u2013Eur."},{"issue":"10","key":"10.1016\/j.msard.2025.106860_bib0008","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/jnnp-2011-300174","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"82","author":"Lucas","year":"2011","journal-title":"J. Neurol. Neurosur. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106860_bib0009","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2012.12.004","article-title":"Association of Epstein\u2013Barr virus infection with multiple sclerosis in India","volume":"325","author":"Pandit","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106860_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103276","article-title":"Multiple sclerosis in Sri Lanka; epidemiology, demographic patterns and current trends","volume":"56","author":"Senanayake","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"17","key":"10.1016\/j.msard.2025.106860_bib0011","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.7314\/APJCP.2015.16.17.7583","article-title":"Seroprevalence of anti-EBV IgG among various age groups from Khon Kaen Province, Thailand","volume":"16","author":"Suntornlohanakul","year":"2015","journal-title":"Asia. Pac. J. Cancer Prevent."},{"issue":"2","key":"10.1016\/j.msard.2025.106860_bib0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.msard.2025.106860_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/v15030714","article-title":"Epstein-Barr Virus history and pathogenesis","volume":"15","author":"Yu","year":"2023","journal-title":"Viruses"},{"issue":"1\u20132","key":"10.1016\/j.msard.2025.106860_bib0014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2009.01.023","article-title":"Gene\u2013environment interactions between HLA B7\/A2, EBV antibodies are associated with MRI injury in multiple sclerosis","volume":"209","author":"Zivadinov","year":"2009","journal-title":"J. Neuroimmunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:29:09Z","timestamp":1781076549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":14,"alternative-id":["S2211034825006029"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106860","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus seropositivity in a cohort of Sri Lankan patients with early multiple sclerosis: Preliminary case control study from South Asia","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106860"}}